DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 4 Jun · 15:06 IST

Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication - Notice to the shareholders regarding transfer of unclaimed dividend(s) and equity shares to Investor Education and Protection Fund (IEPF)

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.8%1-day move
₹6565.00
prior close
₹6598.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.0-0.1+0.8-0.9+2.9+1.5+1.7+0.7+2.1+4.8
Up moveDown movePending
AI summary

Divi's Laboratories has published a newspaper notice informing shareholders that unclaimed dividends and corresponding equity shares will be transferred to the Investor Education and Protection Fund (IEPF) as per statutory requirements. Under SEBI/IEPF rules, dividends unclaimed for seven consecutive years, along with the underlying shares, are liable to be transferred to the IEPF authority. Shareholders who have not claimed their dividends are advised to do so before the deadline to avoid losing ownership of their shares. The notice has been published in compliance with MCA and SEBI regulations.

Likely market impact

This is a routine regulatory compliance filing and does not directly affect the stock price. However, shareholders of Divi's Labs who have any unclaimed dividends should verify their records and take immediate action to claim them before the transfer deadline, or risk losing their shares to the IEPF.